These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19300574)

  • 1. An emerging role for escitalopram in the treatment of obsessive-compulsive disorder.
    Hedges DW; Woon FL
    Neuropsychiatr Dis Treat; 2007 Aug; 3(4):455-61. PubMed ID: 19300574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New treatment options for OCD.
    Fineberg NA
    Int J Psychiatry Clin Pract; 2007; 11 Suppl 2():24-30. PubMed ID: 24926869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escitalopram: a review of its use in the management of anxiety disorders.
    Dhillon S; Scott LJ; Plosker GL
    CNS Drugs; 2006; 20(9):763-90. PubMed ID: 16953656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of serotonin and noradrenaline in anxiety.
    Blier P; El Mansari M
    Int J Psychiatry Clin Pract; 2007; 11 Suppl 2():16-23. PubMed ID: 24926868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessive-compulsive disorder (OCD): response to escitalopram treatment and basal serotonin transporter (SERT) density.
    Wolmarans de W; Brand L; Stein DJ; Harvey BH
    Behav Brain Res; 2013 Nov; 256():545-53. PubMed ID: 24013013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram in obsessive-compulsive disorder: response of symptom dimensions to pharmacotherapy.
    Stein DJ; Carey PD; Lochner C; Seedat S; Fineberg N; Andersen EW
    CNS Spectr; 2008 Jun; 13(6):492-8. PubMed ID: 18567973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escitalopram: a second-generation SSRI.
    Owens MJ; Rosenbaum JF
    CNS Spectr; 2002 Apr; 7(4 Suppl 1):34-9. PubMed ID: 15131491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Escitalopram and citalopram: the unexpected role of the R-enantiomer].
    Jacquot C; David DJ; Gardier AM; Sánchez C
    Encephale; 2007; 33(2):179-87. PubMed ID: 17675913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram: a unique mechanism of action.
    Bræstrup C; Sanchez C
    Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():11-3. PubMed ID: 24930683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A benzisothiazole derivative and antipsychotic agent, perospirone, for augmentation of selective serotonin reuptake inhibitors (SSRIs) in refractory obsessive-compulsive disorder (OCD): two patient case series.
    Matsunaga H; Matsui T; Ohya K; Okino K; Hayashida K; Maebayashi K; Kiriike N; Stein DJ
    Int J Psychiatry Clin Pract; 2006; 10(2):142-5. PubMed ID: 24940965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose escitalopram for the treatment of obsessive-compulsive disorder.
    Rabinowitz I; Baruch Y; Barak Y
    Int Clin Psychopharmacol; 2008 Jan; 23(1):49-53. PubMed ID: 18090508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escitalopram for the treatment of major depression and anxiety disorders.
    Höschl C; Svestka J
    Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders.
    Bareggi SR; Mundo E; Dell'Osso B; Altamura AC
    Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):741-53. PubMed ID: 17916059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escitalopram: a review of its use in the management of major depressive disorder.
    Murdoch D; Keam SJ
    Drugs; 2005; 65(16):2379-404. PubMed ID: 16266205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study.
    Stein DJ; Andersen EW; Tonnoir B; Fineberg N
    Curr Med Res Opin; 2007 Apr; 23(4):701-11. PubMed ID: 17407626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of escitalopram challenge on disgust processing in obsessive-compulsive disorder.
    Lochner C; Simmons C; Kidd M; Chamberlain SR; Fineberg NA; van Honk J; Ipser J; Stein DJ
    Behav Brain Res; 2012 Jan; 226(1):274-80. PubMed ID: 21963422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escitalopram in the treatment of generalized anxiety disorder.
    Baldwin DS; Nair RV
    Expert Rev Neurother; 2005 Jul; 5(4):443-9. PubMed ID: 16026227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram: A New SSRI for the Treatment of Depression in Primary Care.
    Culpepper L
    Prim Care Companion J Clin Psychiatry; 2002 Dec; 4(6):209-214. PubMed ID: 15014711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram: a pharmacoeconomic review of its use in depression.
    Croom KF; Plosker GL
    Pharmacoeconomics; 2003; 21(16):1185-209. PubMed ID: 14594439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and Treatment of Obsessive-Compulsive Disorder (OCD): A Literature Review.
    Elsouri KN; Heiser SE; Cabrera D; Alqurneh S; Hawat J; Demory ML
    Cureus; 2024 May; 16(5):e60496. PubMed ID: 38883111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.